Composition & Format Per vial composition: TB-500 5 mg + BPC-157 5 mg + GHK-Cu 50 mg (total 60 mg) Peptide form: blue copper lyophilized powder in clear glass vials Kit size: 10 vials/kit (standard wholesale pack) Label and tray options can be customized for OEM/private-label projects Key Features for Wholesale Buyers High-purity blend of TB-500, BPC-157 and GHK-Cu for recovery- and skin-focused research models Consistent blue copper appearance for easy visual identification in mixed peptide inventories Factory-direct supply from China with support for bulk orders and rebranding Flexible packaging solutions for distributors, resellers and online peptide shops Batch documentation and quality files can be arranged for regular clients Packaging & Ordering Standard pack: 10 vials/kit, each vial containing 60 mg total peptide content Kits are packed in plastic trays and export cartons, prepared for international shipping For wholesale pricing, OEM options and current lead time , please contact us for a quotation or proforma invoice After payment confirmation, you will receive processing and dispatch updates within around 3 business days Storage & Handling Store vials sealed at 28 C , protected from light and moisture Avoid repeated freezethaw cycles
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
For skin specifically, GHK-Cu has become one of the most studied peptides in cosmetic dermatology
In separate radioactive kinase assays with [ 33 P]--ATP, we incubated recombinant GST-tagged ArfGAP1 deletion mutants (WT or F1-F5) with purified full-length FLAG-tagged LRRK2 (WT, G2019S or D1994A) derived by anti-FLAG IP from transfected SH-SY5Y cells, as described [75]
Therefore, even if a physician were to recommend one of these compounds, there is currently no mechanism to permit use in athletes bound by WADA guidelines
Nasal spray protocol: Dose: 200-500 mcg per application Frequency: 1 to 2 times daily Duration: 4 to 8 weeks Nasal delivery is particularly interesting for researchers focused on neurological applications, as the nasal route provides a potential pathway to bypass the blood-brain barrier through the olfactory and trigeminal nerve pathways
Most of the research right now is preclinical with some early clinical data, so clinicians and patients should consider GHK-Cu a hopeful adjunct, not a sure bet therapy